March 31, 2008 - As part of the Philips cath lab showcase at ACC, the company presented Live 3D TEE technology for the cath lab, designed to give real-time volume rendered images using one-touch...
This may be the Red Bull of interventional cardiology sessions, since The Society of Cardiovascular Angiography and Interventions (SCAI) and ACC’s Innovation in Intervention: i2 Summit joined...
February 28, 2008 - The first human received Medtronic’s investigational bifurcation stent, a Y-shaped design that matches the anatomy of lesions that form at the junctions of coronary arteries,...
February 19, 2008 - A regimen of aspirin, clopidogrel and coumadin started at discharge decreased mortality and major adverse cardiac events (MACE) while keeping bleeding to acceptable levels in...
February 19, 2008 – A novel, fully bioabsorbable salicylate-based stent offers the potential to reduce adverse events associated with current drug-eluting stents (DES) and could be very beneficial...
February 19, 2008 – The first CE certified Nobori Drug-Eluting Coronary Stent System was successfully implanted in Europe, as Terumo Corp. is poised to expand the product from spring 2008 to more...
February 19, 2008 – Clinicians implanted the BioMatrix drug-eluting stent system into the first European patients in a live broadcast during the Joint Interventional Meeting (JIM), held in Rome,...
February 18, 2008 – OrbusNeich’s Genous Bio-engineered R stent is feasible and safe for use in acute myocardial infarction (AMI) patients, according to a paper published in the American Heart...
February 12, 2008 – The FDA, National Heart Lung & Blood Institute (NHLBI) and National Science Foundation, are hosting “Workshop on Computer Methods for Cardiovascular Devices,” on March 18-...
February 7, 2008 - Tryton Medical Inc.’s Side Branch Stent obtains CE Mark approval based on results in the Tryton 1 (First-in-Man Study) with No Side-Branch Restenosis in 30 patients, according...
February 7, 2008 - A Northwestern University Feinberg School of Medicine researcher has launched the first U.S. trial in which a purified form of subjects' own adult stem cells is transplanted...
February 1, 2008 - Stentys' bifurcated stent was successfully implanted recently into a 49-year-old male patient at the ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands, marking...
January 24, 2008 – “Unadjusted mortality…was significantly lower for drug-eluting stents than bare-metal stents in unapproved indications,” noted Donald S.
January 22, 2008 - A new stent with a nanothin surface application shows promise in opening and healing blocked heart arteries without the life-threatening dangers of thrombosis and heart attack...
January 22, 2008 - A new stent with a nanothin surface application known as Polyzene-F shows promise in opening and healing blocked heart arteries reportedly without the potential risks of...
January 10, 2008 - Patients who received OrbusNeich’s Genous Bio-engineered R Stent had significantly fewer major cardiac adverse events (MACE) than patients who received FDA-cleared drug-eluting...
January 8, 2008 - Compared with paclitaxel-eluting stents (PES), sirolimus-eluting stents (SES) appear to decrease the risk of in-stent late luminal loss in diabetics with coronary artery disease...
December 27, 2007 - Several new studies on genetics and stem cell research, along with studies that continue to debate the use of stents to clear coronary artery blockages are among the top...
December 7, 2007 - Edwards Lifesciences Corp. today has entered into a definitive agreement to sell certain assets related to the Edwards LifeStent peripheral vascular product line to C.R. Bard...
November 5, 2007 - A pooled analysis of the E-SIRIUS and C-SIRIUS trials, called New SIRIUS, found that the CYPHER sirolimus-eluting coronary stent continued to provide clinical benefits with...
November 4, 2007 – Drug-eluting stents to open blocked coronary arteries caused no more risks for death or heart attack than bare metal stents, according to a late-breaking outcomes trial...
October 30, 2007 - Cordis Corp. will launch in the U.S. and European its next generation carotid stent system, the PRECISEPRO RX Nitinol Self-Expanding Stent, to treat clogged neck arteries, in...
October 29, 2007 - Boston Scientific Corp. announced positive three-year results from its CABERNET and BEACH carotid artery stenting clinical trials, which evaluated the effectiveness of stenting...
October 25, 2007 - Cordis Corp. announced at TCT 2007 the U.S. and European launch of Cordis’s next generation carotid stent system, the PRECISE PRO RX Nitinol Self-Expanding Stent, designed to...
